Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates

NCT05036161 is registered in ClinicalTrials.gov with Erebouni Medical Center as lead sponsor.

NCT NCT05036161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05036161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates
Lead sponsor
Erebouni Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 6, 2021
Completion date
December 1, 2023
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

predictive value of tests